93 related articles for article (PubMed ID: 9352356)
41. Inhibitory effects of andrographolide on activated macrophages and adjuvant-induced arthritis.
Gupta S; Mishra KP; Singh SB; Ganju L
Inflammopharmacology; 2018 Apr; 26(2):447-456. PubMed ID: 28735448
[TBL] [Abstract][Full Text] [Related]
42. Heparin's anti-inflammatory effects require glucosamine 6-O-sulfation and are mediated by blockade of L- and P-selectins.
Wang L; Brown JR; Varki A; Esko JD
J Clin Invest; 2002 Jul; 110(1):127-36. PubMed ID: 12093896
[TBL] [Abstract][Full Text] [Related]
43. Suppression of TNF-alpha expression, inhibition of Th1 activity, and amelioration of collagen-induced arthritis by rolipram.
Ross SE; Williams RO; Mason LJ; Mauri C; Marinova-Mutafchieva L; Malfait AM; Maini RN; Feldmann M
J Immunol; 1997 Dec; 159(12):6253-9. PubMed ID: 9550429
[TBL] [Abstract][Full Text] [Related]
44. Methotrexate specifically modulates cytokine production by T cells and macrophages in murine collagen-induced arthritis (CIA): a mechanism for methotrexate-mediated immunosuppression.
Neurath MF; Hildner K; Becker C; Schlaak JF; Barbulescu K; Germann T; Schmitt E; Schirmacher P; Haralambous S; Pasparakis M; Meyer Zum Büschenfelde KH; Kollias G; Märker-Hermann E
Clin Exp Immunol; 1999 Jan; 115(1):42-55. PubMed ID: 9933419
[TBL] [Abstract][Full Text] [Related]
45. Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesion.
Woolley DE; Tetlow LC
Arthritis Res; 2000; 2(1):65-74. PubMed ID: 11219391
[TBL] [Abstract][Full Text] [Related]
46. RN486, a selective Bruton's tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents.
Xu D; Kim Y; Postelnek J; Vu MD; Hu DQ; Liao C; Bradshaw M; Hsu J; Zhang J; Pashine A; Srinivasan D; Woods J; Levin A; O'Mahony A; Owens TD; Lou Y; Hill RJ; Narula S; DeMartino J; Fine JS
J Pharmacol Exp Ther; 2012 Apr; 341(1):90-103. PubMed ID: 22228807
[TBL] [Abstract][Full Text] [Related]
47. Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model.
Howard KA; Paludan SR; Behlke MA; Besenbacher F; Deleuran B; Kjems J
Mol Ther; 2009 Jan; 17(1):162-8. PubMed ID: 18827803
[TBL] [Abstract][Full Text] [Related]
48. A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis.
Sumariwalla PF; Gallily R; Tchilibon S; Fride E; Mechoulam R; Feldmann M
Arthritis Rheum; 2004 Mar; 50(3):985-98. PubMed ID: 15022343
[TBL] [Abstract][Full Text] [Related]
49. RWJ 67657, a potent, orally active inhibitor of p38 mitogen-activated protein kinase.
Wadsworth SA; Cavender DE; Beers SA; Lalan P; Schafer PH; Malloy EA; Wu W; Fahmy B; Olini GC; Davis JE; Pellegrino-Gensey JL; Wachter MP; Siekierka JJ
J Pharmacol Exp Ther; 1999 Nov; 291(2):680-7. PubMed ID: 10525088
[TBL] [Abstract][Full Text] [Related]
50. Novel synthetic gluco-disaccharide RSCL-0409--a lipopolysaccharide-induced Toll-like receptor-mediated signalling antagonist.
Kalluri MD; Datla P; Bellary A; Basha K; Sharma A; Sharma A; Singh S; Upadhyay S; Rajagopal V
FEBS J; 2010 Apr; 277(7):1639-52. PubMed ID: 20180845
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of glycinamide ribonucleotide formyltransferase results in selective inhibition of macrophage cytokine secretion in vitro and in vivo efficacy in rat adjuvant arthritis.
Chintalacharuvu S; Evans GF; Shih C; Bryant HU; Sandusky GE; Zuckerman SH
Clin Exp Rheumatol; 2005; 23(4):438-46. PubMed ID: 16095110
[TBL] [Abstract][Full Text] [Related]
52. Inhibitory effect of TRK-530 on inflammatory cytokines in bone marrow of rats with adjuvant arthritis.
Tanahashi M; Koike J; Kawabe N; Nakadate-Matsushita T
Pharmacology; 1998 May; 56(5):237-41. PubMed ID: 9597690
[TBL] [Abstract][Full Text] [Related]
53. Novel inhibitor of p38 MAP kinase as an anti-TNF-alpha drug: discovery of N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]-2-pyridyl]benzamide (TAK-715) as a potent and orally active anti-rheumatoid arthritis agent.
Miwatashi S; Arikawa Y; Kotani E; Miyamoto M; Naruo K; Kimura H; Tanaka T; Asahi S; Ohkawa S
J Med Chem; 2005 Sep; 48(19):5966-79. PubMed ID: 16162000
[TBL] [Abstract][Full Text] [Related]
54. The cell-penetrating peptide domain from human heparin-binding epidermal growth factor-like growth factor (HB-EGF) has anti-inflammatory activity in vitro and in vivo.
Lee JY; Seo YN; Park HJ; Park YJ; Chung CP
Biochem Biophys Res Commun; 2012 Mar; 419(4):597-604. PubMed ID: 22342671
[TBL] [Abstract][Full Text] [Related]
55. Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro.
Ling Y; Yang ZY; Yin T; Li L; Yuan WW; Wu HS; Wang CY
Int Immunopharmacol; 2011 Feb; 11(2):187-93. PubMed ID: 21095260
[TBL] [Abstract][Full Text] [Related]
56. Subcutaneous injections of a TNF-alpha antagonistic peptide inhibit both inflammation and bone resorption in collagen-induced murine arthritis.
Kojima T; Aoki K; Nonaka K; Saito H; Azuma M; Iwai H; Varghese BJ; Yoshimasu H; Baron R; Ohya K; Amagasa T
J Med Dent Sci; 2005 Mar; 52(1):91-9. PubMed ID: 15868746
[TBL] [Abstract][Full Text] [Related]
57. Tumor necrosis factor-α blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation.
Sade-Feldman M; Kanterman J; Ish-Shalom E; Elnekave M; Horwitz E; Baniyash M
Immunity; 2013 Mar; 38(3):541-54. PubMed ID: 23477736
[TBL] [Abstract][Full Text] [Related]
58. A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation.
Mourey RJ; Burnette BL; Brustkern SJ; Daniels JS; Hirsch JL; Hood WF; Meyers MJ; Mnich SJ; Pierce BS; Saabye MJ; Schindler JF; South SA; Webb EG; Zhang J; Anderson DR
J Pharmacol Exp Ther; 2010 Jun; 333(3):797-807. PubMed ID: 20237073
[TBL] [Abstract][Full Text] [Related]
59. Effects of the somatostatin receptor subtype 4 selective agonist J-2156 on sensory neuropeptide release and inflammatory reactions in rodents.
Helyes Z; Pintér E; Németh J; Sándor K; Elekes K; Szabó A; Pozsgai G; Keszthelyi D; Kereskai L; Engström M; Wurster S; Szolcsányi J
Br J Pharmacol; 2006 Oct; 149(4):405-15. PubMed ID: 16953190
[TBL] [Abstract][Full Text] [Related]
60. Esculin exhibited anti-inflammatory activities in vivo and regulated TNF-α and IL-6 production in LPS-stimulated mouse peritoneal macrophages in vitro through MAPK pathway.
Niu X; Wang Y; Li W; Zhang H; Wang X; Mu Q; He Z; Yao H
Int Immunopharmacol; 2015 Dec; 29(2):779-786. PubMed ID: 26391063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
